#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Emphysema Skin cancer Stevens-Johnson syndrome Paroxysmal nocturnal haemoglobinuria Corneal neovascularisation Vitamin B12 deficiency Hypophosphatasia C3 glomerulopathy Primary immunodeficiency syndrome Hyperadrenocorticism Endometrial cancer recurrent Krabbe's disease Myasthenia gravis Penile squamous cell carcinoma Splenic marginal zone lymphoma More trials…

    Learn about Rare Diseases

    Lysosomal storage disorder Wolfram syndrome – Trials in Disease Angiosarcoma recurrent – Trials in Disease Mucopolysaccharidosis III – Trials in Disease Congenital hypotransferrinaemia Vascular malformation – Diagnostics Wiskott-Aldrich syndrome – Trials in Disease Splenic marginal zone lymphoma – Diagnostics Hyperoxaluria – Diagnostics Castleman’s disease – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Absk021 Hydrochloride Hydrate Daridorexant Caspofungin Acetate Oteracil Zalunfiban Suxamethonium Chloride Ucp2 Vgl101 ULVIPRUBART Lanifibranor Sargramostim Oxymetazoline Hydrochloride Milrinone Flecainide Acetate YOHIMBINE HYDROCHLORIDE Evx-01 Methylprednisolone Aceponate Carboplatin TRIACYLGLYCEROL LIPASE Phenylbutyrate More therapies…

    Learn about Your Condition

    Paedophilia Neurodegenerative disorder Primary hypogonadism Acoustic neuroma Erythema multiforme Peripheral ischaemia Arthroscopy Metastases to lymph nodes Polyneuropathy Splenic marginal zone lymphoma Shock Dermatitis Head injury Appendicitis Burkitt's lymphoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Surgical Procedures, Operative

  • Comparing intermediate and standard doses of enoxaparin to prevent blood clots in patients with severe trauma

    Not yet recruiting

    4 1 1
    Investigated Diseases:
    • Thrombosis prophylaxis
    Investigated Drugs:
    • Sodium Chloride
    • Enoxaparin Sodium
    France

  • A study testing magnesium aspartate to prevent long-term low parathyroid hormone levels in patients after thyroid surgery

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Hypoparathyroidism
    Investigated Drugs:
    • MAGNESIUM L-ASPARTATE HYDROCHLORIDE TRIHYDRATE
    Greece

  • Study of dexmedetomidine compared to midazolam to reduce delirium in critically ill children on breathing machines in intensive care

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Dexmedetomidine
    • Midazolam
    France

  • Study of Anti-GD2-800CW for Imaging in Children with Neuroblastoma

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • ANTI-GD2-800CW
    The Netherlands

  • Study on the Effect of Methylprednisolone Injection for Reducing Swelling, Stiffness, and Pain After Lower Wisdom Tooth Surgery in Patients

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Post procedural complication
    Investigated Drugs:
    • Methylprednisolone Hemisuccinate
    Hungary

  • Study on Glioblastoma Treatment with Temozolomide, Lomustine, and Perflutren for Newly Diagnosed Patients

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Glioblastoma
    Investigated Drugs:
    • Lomustine
    • Perflutren
    • Temozolomide
    Belgium France
Previous Page
1 … 6 7 8 9 10 … 12
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!